Rite Aid Corp (RAD)
$9.13 0.00 (0.00%)
19:08 EDT RAD Stock Quote Delayed 15 Minutes
Previous Close $1.11
Market Cap 9.74B
PE Ratio -26.85
Volume (Avg. Vol.)
Day's Range 9.13 - 9.13
52-Week Range 0.43 - 11.37
Dividend & Yield N/A (N/A)
RAD Stock Predictions, Articles, and Rite Aid Corp News
- From InvestorPlace
- From the Web
History says that Sell ratings from Wall Street are meaningful and predictive, so investors should shy away from these five stocks to sell.
RAD stock both rallied by 50% and dropped by 30% in September - and none of it had anything to do with the fundamentals of Rite Aid stock, which remain bad.
Rite Aid stock – don’t wait for any management-led turnaround. This pharmacy retailer is laden with debt, cash flow losses and no clear turnaround plan.
By Thomas Niel
With this in mind, the stock is a hard pass. Investors likely can find more solid turnaround plays elsewhere. Given the volatility in the RAD stock prices, shares could shoot higher on speculation. But long term, Rite Aid stock is not a strong investment opportunity.
Rite Aid (NYSE:RAD) jumped more than 20% last week after exceeding second-quarter earnings guidance. The boost came at a good time. Rite Aid stock has....
Value is back in favor, and as it has come back in favor, these beaten-up value stocks have soared higher over the past month.
With Rite Aid reporting Q2 earnings on Thursday, all eyes will focus on the pharmacy retailer’s forward guidance. Unfortunately, that might not be a good thing for RAD stock.
Rite Aid stock has a chance of recovering but the new CEO has plenty of work ahead. The company must grow prescription volumes and sales.
It was a slow session in the stock market today, with little gains showing up on Monday. Here's what happened in the U.S. stock market.
RAD stock looks tempting here in the midst of this lull, but what Rite Aid needs to do the most is the one thing that will be toughest to do.
With the RAD stock price down 95%, value investors might be intrigued. But there are better risk-adjusted plays than Rite Aid stock.
As with most investments, the future of Rite Aid stock depends on millennials. Here, new Rite Aid CEO Heyward Donigan has both an opportunity as well as significant risks.
Despite its cheap price, Rite Aid stock is hardly what you would call a discount. Instead, it’s a junk equity that you should steer clear from, considering that it doesn’t have an Amazon Counter-like catalyst in the foreseeable future.
RAD stock has been in an awful downtrend... for 15 years. But there's still some value and opportunity here.
By David Moadel
Rite Aid stock is not for the faint of heart, but RAD stock could surprise the critics and enrich the intrepid.
Sunday’s Midday Stock Update: Rite Aid Corp (RAD), Virnetx Holding Corp (VHC), Exelixis (EXEL), Intercept Pharma (ICPT), uniQure NV (QURE)
From Analyst Ratings
So far Sunday, October 6, NASDAQ is up 3.07% and the S&P is up 3.21%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Rite Aid Corp (RAD – Research Report), Virnetx Holding Corp (VHC – Research Report), Exelixis (EXEL – Research Report), Intercept Pharma (ICPT – Research Report)
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!